GlaxoSmithKline Gets FDA Panel Recommendation For Kidney Cancer ... - RTT News PDF Print
RTT NewsThe panel indicated the benefit-to-risk profile as acceptable for patients with advanced renal cell carcinoma. Pazopanib is an investigational,

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.